Moderna (MRNA) News Today → Does this make you sick? (From Allegiance Gold) (Ad) Free MRNA Stock Alerts $132.90 +0.22 (+0.17%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 6:29 AM | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Stake Cut by Dimensional Fund Advisors LPDimensional Fund Advisors LP decreased its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 28.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,307,164 shares of the company's stock after selling 530,849 shMay 19 at 4:38 AM | insidertrades.comNoubar Afeyan Sells 15,000 Shares of Moderna, Inc. (NASDAQ:MRNA) StockMay 18 at 8:59 AM | insidertrades.comInsider Selling: Moderna, Inc. (NASDAQ:MRNA) Director Sells 15,000 Shares of StockMay 17 at 9:57 PM | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Director Sells $1,909,800.00 in StockModerna, Inc. (NASDAQ:MRNA - Get Free Report) Director Noubar Afeyan sold 15,000 shares of the stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $127.32, for a total value of $1,909,800.00. Following the transaction, the director now directly owns 1,996,931 shares in the company, valued at approximately $254,249,254.92. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.May 17 at 9:00 PM | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Acquired by Nikko Asset Management Americas Inc.Nikko Asset Management Americas Inc. lifted its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 130.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 288,779 shares of the company's stock after purchMay 17 at 8:10 PM | wsj.comA Moderna Patent Bailout Would Set a Dangerous PrecedentMay 17 at 3:09 PM | theglobeandmail.comModerna wins patent case in Europe against Pfizer, BioNTech over COVID shotMay 17 at 3:09 PM | ft.comModerna wins case in patent dispute with Pfizer and BioNTech over Covid jabMay 17 at 3:09 PM | msn.comModerna vaccine patent upheld by European Patent Office: reportMay 17 at 12:00 PM | reuters.comModerna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reportsMay 17 at 5:40 AM | fool.comCould Novavax Become the Next Moderna?May 16 at 2:37 PM | finance.yahoo.comBiotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMYMay 16 at 7:56 AM | marketbeat.comJump Financial LLC Buys 11,080 Shares of Moderna, Inc. (NASDAQ:MRNA)Jump Financial LLC increased its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 402.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,835 shares of the company's stock after buying an additional 11,08May 16 at 6:38 AM | americanbankingnews.comModerna (NASDAQ:MRNA) Upgraded by Evercore ISI to HoldMay 16 at 3:32 AM | americanbankingnews.comModerna (NASDAQ:MRNA) Coverage Initiated by Analysts at Evercore ISIMay 15, 2024 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Acquires 23,288 Shares of Moderna, Inc. (NASDAQ:MRNA)Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 6.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 386,741 shares of the company's stock after purchasing aMay 15, 2024 | seekingalpha.comModerna Q1: A Promising Pipeline Is UndervaluedMay 15, 2024 | msn.comModerna Japan aiming for combined COVID-flu mRNA vaccine clinical trials this winterMay 14, 2024 | msn.comEvercore ISI Group Initiates Coverage of Moderna (MRNA) with In-Line RecommendationMay 14, 2024 | finance.yahoo.comModerna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?May 14, 2024 | marketbeat.comModerna (NASDAQ:MRNA) Now Covered by Evercore ISIEvercore ISI assumed coverage on shares of Moderna in a research report on Tuesday. They set an "in-line" rating and a $120.00 target price on the stock.May 14, 2024 | marketbeat.comTeacher Retirement System of Texas Sells 10,124 Shares of Moderna, Inc. (NASDAQ:MRNA)Teacher Retirement System of Texas lowered its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 11.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 75,700 shares of the company's stockMay 14, 2024 | fool.comIs This a Setback for Moderna?May 14, 2024 | americanbankingnews.comModerna, Inc. (NASDAQ:MRNA) President Stephen Hoge Sells 255 Shares of StockMay 14, 2024 | insidertrades.comInsider Selling: Moderna, Inc. (NASDAQ:MRNA) President Sells 255 Shares of StockMay 13, 2024 | marketbeat.comModerna (NASDAQ:MRNA) Shares Up 8%Moderna (NASDAQ:MRNA) Stock Price Up 8%May 13, 2024 | marketbeat.comStephen Hoge Sells 255 Shares of Moderna, Inc. (NASDAQ:MRNA) StockModerna, Inc. (NASDAQ:MRNA - Get Free Report) President Stephen Hoge sold 255 shares of the stock in a transaction on Friday, May 10th. The stock was sold at an average price of $120.96, for a total value of $30,844.80. Following the completion of the sale, the president now directly owns 1,486,508 shares in the company, valued at $179,808,007.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.May 13, 2024 | finance.yahoo.comCompany News For May 13, 2024May 13, 2024 | finance.yahoo.comWhile shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunateMay 13, 2024 | fool.comBull Market and Beyond: 2 Stocks Just Waiting to SoarMay 13, 2024 | msn.comExperts Dismiss Fears Over mRNA Vaccines Following AstraZeneca ExitMay 12, 2024 | marketbeat.comDana Investment Advisors Inc. Has $1.13 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)Dana Investment Advisors Inc. raised its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 193.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,312 shares of the company's stock afMay 12, 2024 | fool.comModerna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?May 11, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by Mawer Investment Management Ltd.Mawer Investment Management Ltd. cut its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 1.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,795,949 shares of the company's stock aMay 11, 2024 | bizjournals.comFDA delays decision date for Moderna's RSV vaccineMay 11, 2024 | markets.businessinsider.comModerna: FDA Delays BLA Review Of RSV Vaccine MRNA-1345May 11, 2024 | msn.comModerna says FDA will not complete review of RSV vaccine by May 12 deadlineMay 10, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Stake Boosted by Intrinsic Value Partners LLCIntrinsic Value Partners LLC lifted its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 32.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,371 shares of the company's stock after buying anMay 10, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Director Sells $1,825,200.00 in StockModerna, Inc. (NASDAQ:MRNA - Get Free Report) Director Noubar Afeyan sold 15,000 shares of the firm's stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $121.68, for a total transaction of $1,825,200.00. Following the completion of the sale, the director now owns 2,011,931 shares of the company's stock, valued at $244,811,764.08. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.May 10, 2024 | investopedia.comModerna Stock Slips as FDA Delays RSV Vaccine ApprovalMay 10, 2024 | marketbeat.comWill the Biotech Sector Shift From Lagger to Leader?The biotech sector and its popular ETF, the iShares Biotechnology ETF NASDAQ: IBB, have lagged the overall market during the year, with its shares slightly red. However, in recent weeks, the sector has enjoyed a significant rally after bouncing off its uptrend support and now consolidating near several major Simple Moving Averages (SMA).May 10, 2024 | marketbeat.comWill the Biotech Sector Shift From Lagger to Leader?The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.May 10, 2024 | reuters.comUS FDA pushes decision on Moderna's RSV vaccine to end of this monthMay 10, 2024 | cnbc.comModerna says FDA delayed RSV vaccine approval to end of MayMay 9, 2024 | msn.comModerna’s First Vaccine Was a Big Hit. Its Second Is a Let DownMay 9, 2024 | finance.yahoo.comPositive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past yearMay 9, 2024 | msn.comModerna's New RSV Vaccine Undercuts the Promise of mRNAMay 9, 2024 | marketbeat.comNational Pension Service Acquires 19,961 Shares of Moderna, Inc. (NASDAQ:MRNA)National Pension Service raised its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 2.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 712,056 shares of the company's stock after buying anMay 9, 2024 | fool.comIf You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have TodayMay 9, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) PT Raised to $151.00 at UBS Group Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address This consistently signaled gains of 453%... 610%... and even 1036%... (Ad)It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade. Register for the imminent briefing here. MRNA Media Mentions By Week MRNA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.670.42▲Average Medical News Sentiment MRNA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼3518▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Seagen News Biogen News argenx News BioNTech News Neurocrine Biosciences News Bio-Techne News Gilead Sciences News Qiagen News Repligen News CRISPR Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaUrgent Nvidia WarningAltimetryDems have chosen Biden replacement?Paradigm PressMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
